Care and treatment

Resource
March 4, 2019

The emergence and expansion of the multidrug-resistant tuberculosis epidemic is a threat to the global control of tuberculosis. Multidrug-resistant tuberculosis is the result of the selection of resistance-conferring mutations during inadequate antituberculosis treatment.

Resource
February 27, 2019
In South Africa, roughly half of the drug-resistant TB cases diagnosed are reported to have been started on treatment. We determined the proportion of persons diagnosed with rifampicin resistant (RR-) TB who initiated treatment in Johannesburg after the introduction of decentralized RR-TB care in 2011.
Event
February 27, 2019

This webinar, on addressing the SRH needs of adolescents and young people living with HIV , which is part of the 2019 SRHR and HIV Linkages webinar series

Blog
February 26, 2019

The first-ever UN high level meeting on tuberculosis (TB) on 26 September 2018 in New York was a crucial political moment for TB.

News
February 26, 2019

Preventing maternal and child deaths, creating an AIDS-free generation, and protecting communities from infectious disease threats needs efficient pharmaceutical services and treatment with quality medicines.

Opportunity
February 25, 2019
Panagora Group's Monitoring, Evaluation, Research, and Learning (MERL) Activity supports USAID/South Africa’s bilateral Health Office by working collaboratively with health office staff to achieve their overall goals by creatively finding innovative solutions, supplementing and complementing their existing staff capacity, and as appropriate enhancing capacity in performance management; evaluation and research; and systematic collaboration, continuous learning, and adaptive management. We are looking for creative, dynamic, results focused and experienced professionals to be part of a pool of consultants that we can call on to support USAID/South Africa’s bilateral Health Office with a variety of needs in the area of HIV and AIDS.
Resource
February 21, 2019

We assessed the relationship between distance to clinic and progression through the HIV care cascade. We have two key findings. First, distance matters but only for women. Second, for women, distance affected linkage to care, but was not associated with later transitions in the care cascade.

Resource
February 21, 2019
Treatment success rates of rifampicin resistant (RR)/multi-drug resistant (MDR) tuberculosis (TB) in South Africa range from 43–48%, falling short of the World Health Organization’s target of ≥75%. We present rates and assess predictors of attrition by 12 months on treatment.
Resource
February 21, 2019
We describe baseline characteristics, time to treatment initiation and interim patient outcomes at a decentralized, outpatient treatment site for rifampicin-resistant TB (RR-TB).
Resource
February 21, 2019
Depression is a leading cause of disability and may be associated with decreased adherence to ART. We sought to describe the prevalence of depressive symptoms and outcomes one year after screening among patients receiving ART at a large HIV Clinic in Johannesburg, South Africa.